<DOC>
	<DOCNO>NCT01772290</DOCNO>
	<brief_summary>This randomize , open-label , 4-arm , multiple-dose study evaluate effect coadministration protein pump inhibitor , inhibitor P-glycoprotein CYP3A4 , inhibitor CYP2C9 pharmacokinetics vismodegib healthy female subject non-childbearing potential . Subjects randomize receive multiple oral dos vismodegib , alone combination multiple oral dos either rabeprazole , itraconazole fluconazole . Anticipated time study treatment 11 day .</brief_summary>
	<brief_title>A Drug-Drug Interaction Study Effect Rabeprazole , Itraconazole Fluconazole Pharmacokinetics Vismodegib</brief_title>
	<detailed_description />
	<mesh_term>Rabeprazole</mesh_term>
	<mesh_term>Itraconazole</mesh_term>
	<mesh_term>Fluconazole</mesh_term>
	<mesh_term>Hydroxyitraconazole</mesh_term>
	<criteria>Females nonchildbearing potential Body mass index ( BMI ) 18 32 kg/m2 , inclusive In good health , determine clinically significant finding medical history , physical examination . 12lead ECG , vital sign Clinical laboratory evaluation , complete blood count urinalysis within normal range test laboratory , unless deem clinically significant investigator Negative test drug abuse screen checkin ( include alcohol ) Negative hepatitis B , hepatitis C HIV infection Nonchildbearing potential define : nonpregnant , nonlactating , either postmenopausal least 1 year surgically sterile ( e.g . bilateral oophorectomy and/or hysterectomy ) Significant history clinical evidence metabolic ( include type 1 2 diabetes ) . allergic , dermatological , hepatic , renal , hematological , pulmonary , cardiovascular , endocrine , GI ( include gastric duodenal ulcer ) , ZollingerEllison syndrome , Barrett 's esophagus , urological , neurological , psychiatric disorder History inflammatory arthritis History symptomatic hypotension History seizure disorder History bipolar major depressive disorder History stomach intestinal surgery resection would potentially alter absorption and/or excretion orally administer drug ( appendectomy , hernia repair , and/or cholecystectomy allow ) History alcoholism drug addiction within 1 year prior checkin Use tobacco nicotinecontaining product within 6 month prior checkin Participation investigational study drug biological agent trial receipt investigational study drug occur within 5 halflives 30 day , whichever longer , prior checkin Use PPIs , H2receptor antagonists , antacid within 1 month prior checkin History chronic PPI use ( &gt; 30 day continuous daily dose ) within 6 month checkin</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>